Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics (2020)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; DUARTE, GERALDO - FMRP ; MOISÉS, ELAINE CHRISTINE DANTAS - FMRP ; MOREIRA, FERNANDA DE LIMA - FCFRP ; PINTO, LEONARDO SANTOS RIBEIRO - FMRP ; NARDOTTO, GLAUCO HENRIQUE BALTHAZAR - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1007/s11095-020-02854-4
- Subjects: ANTIDEPRESSIVOS; FARMACOCINÉTICA; GRAVIDEZ; ESTUDOS DE CASOS E CONTROLES; MUCOSA INTESTINAL; ANTI-HISTAMÍNICOS
- Keywords: CPKA-D-20-00095; P-gp; Fexofenadine; Fluoxetine; Pharmacokinetics; Pregnancy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutical Research
- ISSN: 0724-8741
- Volume/Número/Paginação/Ano: v. 37, n. 7, art. 131, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, v. 37, n. 7, 2020Tradução . . Disponível em: https://doi.org/10.1007/s11095-020-02854-4. Acesso em: 23 maio 2025. -
APA
Pinto, L. S. R., Moreira, F. de L., Nardotto, G. H. B., Cavalli, R. de C., Moisés, E. C. D., Duarte, G., & Lanchote, V. L. (2020). Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, 37( 7). doi:10.1007/s11095-020-02854-4 -
NLM
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2025 maio 23 ] Available from: https://doi.org/10.1007/s11095-020-02854-4 -
Vancouver
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2025 maio 23 ] Available from: https://doi.org/10.1007/s11095-020-02854-4 - Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model
- Transplacental distribution of lidocaine and its metabolite in peridural anesthesia administered to patients with gestational diabetes mellitus
- Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women
- Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women
- Effects of maternal obesity on the delivery outcome during labor induction with misoprostol
- Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women
- Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women
- Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women
- Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model
- Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]
Informações sobre o DOI: 10.1007/s11095-020-02854-4 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003033255.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
